Live Breaking News & Updates on Anant Narayan Bhatt

Stay updated with breaking news from Anant narayan bhatt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Rajnath Singh to release first batch of DRDO's 2DG medicine for treating COVID-19 patients today


Union Defence Minister, Rajnath Singh (Photo/ANI)
Rajnath Singh to release first batch of DRDO s 2DG medicine for treating COVID-19 patients today
ANI |
Updated: May 17, 2021 04:49 IST
New Delhi [India], May 17 (ANI): The first batch of the 2-deoxy-D-glucose (2-DG) drug developed by the Defence Research and Development Organisation (DRDO) for treatment of Covid-19 will be released by Defence Minister Rajnath Singh on Monday.
Rajnath Singh s office tweeted, Raksha Mantri Rajnath Singh will release the first batch of anti-Covid drug 2DG via video conferencing facility tomorrow at 10.30 AM. The drug has been developed by DRDO s Institute of Nuclear Medicine and Allied Sciences (INMAS) in collaboration with Dr Reddy s Laboratories. ....

Andhra Pradesh , New Delhi , Tamil Nadu , Uttar Pradesh , Rajnath Singh , Narendra Modi , Raksha Mantri Rajnath Singh , Anant Narayan Bhatt , Centre For Cellular , Institute Of Nuclear Medicine , Central Drugs Standard Control Organization , Ministry Of Defence , Development Organisation , Defence Research , Defence Minister Rajnath Singh , Mantri Rajnath Singh , Nuclear Medicine , Allied Sciences , Prime Minister Narendra Modi , Molecular Biology , Drugs Controller General , West Bengal , Emergency Use , Anti Covid Drug , Ministry Of Defence , ஆந்திரா பிரதேஷ் ,

Rajnath Singh to release first batch of DRDO's 2DG Covid medicine today


The first batch of the 2-deoxy-D-glucose (2-DG) drug developed by the Defence Research and Development Organisation (DRDO) for treatment of Covid-19 will be released by Defence Minister Rajnath Singh on Monday.
Rajnath Singh s office tweeted, Raksha Mantri Rajnath Singh will release the first batch of anti-Covid drug 2DG via video conferencing facility tomorrow at 10.30 AM. The drug has been developed by DRDO s Institute of Nuclear Medicine and Allied Sciences (INMAS) in collaboration with Dr Reddy s Laboratories.
The first batch of 10,000 doses of 2DG medicine would be launched early next week, informed Defence Research and Development Organisation officials to ANI on Friday. ....

Uttar Pradesh , Andhra Pradesh , Tamil Nadu , Rajnath Singh , Narendra Modi , Raksha Mantri Rajnath Singh , Anant Narayan Bhatt , Centre For Cellular , Institute Of Nuclear Medicine , Central Drugs Standard Control Organization , Ministry Of Defence , Development Organisation , Defence Research , Defence Minister Rajnath Singh , Mantri Rajnath Singh , Nuclear Medicine , Allied Sciences , Prime Minister Narendra Modi , Molecular Biology , Drugs Controller General , West Bengal , Emergency Use , Drdo 2dg Medicines , 2dg Covid Medicine , Defence Minister Rajnath Singh , Defence Research And Development Organisation ,

DRDO to launch 2-DG drug for COVID-19 treatment next week


DRDO to launch 2-DG drug for COVID-19 treatment next week
The first batch of 10,000 doses of 2DG medicine for treating coronavirus patients will be launched early next week, informed Defence Research and Development Organisation (DRDO) officials
BusinessToday.In | May 15, 2021 | Updated 11:53 IST
The 2-DG drug helps in faster recovery of the hospitalised COVID-19 patients and also lessens oxygen dependence
The first tranche of 10,000 doses of 2-DG medicine for treating coronavirus patients will be launched early next week, informed Defence Research and Development Organisation (DRDO) officials on Friday, May 14.
The 2-DG (2-deoxy-D-glucose), an anti-COVID-19 therapeutic application of the drug, has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddys Laboratories (DRL), Hyderabad. ....

Andhra Pradesh , Anant Narayan Bhatt , Karnataka Health , Institute Of Nuclear Medicine , Development Organisation , Defence Research , Nuclear Medicine , Allied Sciences , Health Minister , Oxycare System , Oxygen Supply System , Defence Research And Development Organisation , Drdo 2dg Drug , 2dg Drug , Covid 19 Treatment , Covid 19 Patients , Drdo Covid19 Drug , 2dg Covid19 Drug , Covid Vaccine , Coronavirus Vaccine , ஆந்திரா பிரதேஷ் , கர்நாடகா ஆரோக்கியம் , நிறுவனம் ஆஃப் அணு மருந்து , வளர்ச்சி ஆர்கநைஸேஶந் , பாதுகாப்பு ஆராய்ச்சி , அணு மருந்து ,